[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100410442":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":18,"responsibleParty":36,"collaborators":7,"id":38,"slug":7,"hasResults":39,"nctId":40,"briefTitle":41,"officialTitle":41,"acronym":7,"eligibilityCriteria":42,"healthyVolunteers":39,"sex":43,"minAge":44,"maxAge":7,"enrollmentInfo":45,"targetDuration":7,"studyType":48,"phases":7,"briefSummary":49,"conditions":50,"keywords":7,"overallStatus":21,"whyStopped":7,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":65},{"fullName":5,"class":6},"Case Comprehensive Cancer Center","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Gregory Cooper, MD","University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center","PRINCIPAL_INVESTIGATOR",[14],{"name":10,"role":15,"phone":16,"phoneExt":7,"email":17},"CONTACT","1-800-641-2422","gregory.cooper@uhhospitals.org",[19],{"facility":20,"status":21,"city":22,"state":23,"zip":24,"country":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center","RECRUITING","Cleveland","Ohio","44106","United States",{"type":27,"coordinates":28},"Point",[29,30],-81.69541,41.4995,{"lat":30,"lon":29},[33],{"name":10,"role":15,"phone":34,"phoneExt":7,"email":35},"800-641-2422","CTUReferral@UHhospitals.org",{"type":37,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100410442",false,"NCT04624555","The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors","Inclusion Criteria:\n\n* Diagnosis of stage I, II or III adenocarcinoma of the colon or rectum\n* Receipt of preoperative colonoscopy\n* Receipt of bowel resection; use of adjuvant chemotherapy or radiation therapy as clinically indicated\n\nExclusion Criteria:\n\n* Stage IV colorectal cancer\n* Surgical treatment with subtotal colectomy or total proctocolectomy\n* Diagnosis of inflammatory bowel disease (ulcerative colitis or Crohn's disease)\n* Diagnosis of polyposis syndrome including Lynch syndrome or familial polyposis\n* Presence of advanced adenomas (1 cm or larger, villous features and\u002For high grade dysplasia) that were not removed at the preoperative colonoscopy or contained in the resection specimen.\n* Inability to provide informed consent\n* Inability to understand spoken and written English\n* Medical comorbidities that would be contraindications to sedation or that would preclude any benefit of routine surveillance post-resection. These would be at the discretion of the participant's providers.","ALL","18 Years",{"count":46,"type":47},50,"ESTIMATED","OBSERVATIONAL","The purpose of this research study is to determine whether testing of stool for a panel of markers will enable us to detect polyps and cancer compared to standard testing.",[51,52,53,54,55],"Adenocarcinoma of the Colon","Adenocarcinoma of the Rectum","Stage I Colorectal Cancer","Stage II Colorectal Cancer","Stage III Colorectal Cancer","2026-04-06",{"date":58,"type":59},"2026-04-09","ACTUAL",{"date":61,"type":59},"2022-10-31",{"date":63,"type":47},"2026-09-01",{"name":5,"class":6},1]